Novozymes A/S (OTCMKTS:NVZMY) Upgraded at Barclays

Barclays upgraded shares of Novozymes A/S (OTCMKTS:NVZMY) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.

NVZMY has been the topic of several other research reports. Berenberg Bank raised shares of Novozymes A/S to a “strong-buy” rating in a research note on Tuesday, September 24th. Citigroup lowered shares of Novozymes A/S from a “neutral” rating to a “sell” rating in a report on Thursday, October 17th.

Novozymes A/S Stock Up 1.3 %

Shares of NVZMY opened at $57.26 on Monday. The stock’s fifty day simple moving average is $65.64 and its 200-day simple moving average is $63.83. The firm has a market capitalization of $26.81 billion, a PE ratio of 36.24, a price-to-earnings-growth ratio of 3.87 and a beta of 0.90. Novozymes A/S has a 12-month low of $49.99 and a 12-month high of $72.50.

Novozymes A/S Cuts Dividend

The business also recently announced a dividend, which was paid on Wednesday, September 18th. Shareholders of record on Monday, September 9th were paid a $0.1678 dividend. The ex-dividend date of this dividend was Monday, September 9th. Novozymes A/S’s payout ratio is 41.77%.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.